ClinicalTrials.Veeva

Menu

NIRS and Doppler to Predict NEC in Risk Neonates (NeoNIRS)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Necrotizing Enterolitis

Treatments

Device: Cerebral and splanchnic ear infrared spectroscopy (NIRS) and mesenteric Doppler

Study type

Interventional

Funder types

Other

Identifiers

NCT01833000
9048 (Other Identifier)

Details and patient eligibility

About

The main objective is to evaluate the interest of cerebro-splanchnic oxygenation ratio (CSOR) for early diagnosis of necrotizing enterocolitis (NEC) in neonates with rectal bleeding and/or abdominal distension. CSOR will be determined using near infrared spectroscopy (NIRS).

Enrollment

69 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • less than 28 days neonates hospitalised in neonatology care unit presenting rectal bledding and/or abdominal distension
  • signed authorization by the parents (consent form)

Exclusion criteria

    • cutaneous lesions in the regions of monitoring
  • emergency for NEC

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

69 participants in 1 patient group

newborn suspected to suffer from necrotizing enterolitis
Other group
Description:
Cerebral and splanchnic ear infrared spectroscopy (NIRS) and mesenteric Doppler
Treatment:
Device: Cerebral and splanchnic ear infrared spectroscopy (NIRS) and mesenteric Doppler

Trial contacts and locations

1

Loading...

Central trial contact

Gilles Cambonie, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems